psoriasis vulgaris
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Patients with mild to moderate psoriasis vulgaris according to the diagnostic criteria. (2) PASI score<10 points, BSA<10%, DLQI<10 points. (3) According to the analysis of Uyghur medicine differentiation, patients with psoriasis vulgaris who meet the diagnosis of salty mucus. (4) Age range from 18 to 65 years old. (5) Informed consent, voluntary testing
Exclusion criteria
Exclusion criteria: (1) Tuberculosis and tumor patients. (2) Combined with severe cardiac insufficiency, severe primary diseases such as liver and kidney systems. (Note: ALT and AST exceed the upper limit of the normal range by 2 times, while Cr exceeds the upper limit of the normal range.) (3) Have taken steroids or any medication to treat psoriasis within the past 2 weeks; Have taken retinoic acid drugs or topical steroid preparations and any topical medication for the treatment of psoriasis within one week. (4) Plan for pregnant, pregnant, or lactating women. (5) Suspected or confirmed history of alcohol or drug abuse. (6) Allergic constitution (allergic to two or more other drugs), or allergic to the drug components in this plan. (7) Other situations that may reduce the likelihood of enrollment or complicate enrollment, such as frequent changes in the work environment, mental disorders, communication difficulties, etc., are deemed unsuitable by the researchers to participate in this clinical trial. (8) Individuals who have participated in clinical trials of other drugs within the past month or are currently participating in other clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| psoriasis area and severity index,PASI; | — |
Secondary
| Measure | Time frame |
|---|---|
| Uyghur Medical Syndrome Score;Post effect of 18 weeks;Dermatology Life Quality Index, DLQI;Affected area of body surface,BSA; | — |
Countries
China
Contacts
Hospital of Xinjiang Traditional Uyghur Medicine